This message was sent to ##Email##
|
| December 28, 2016 |
| |  | | |
|
|
|
| |
|
As 2016 comes to a close, ASCT would like to wish its members, partners and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of ASCT Viewpoint a look at the most accessed articles from the year. Our regular publication will resume Wednesday, Jan. 11.
|
ASCT
If you've been wondering how you can make a difference in your profession, how you can have a voice in the issues that directly impact you…wonder no more! ASCT is what you've been looking for!
The ASCT Executive Council, the Society’s governing body, is made up of 5 Regional Directors, President, President-Elect, Treasurer and Legislative Consultant. ASCT is now seeking nominees for President-Elect and Regional Directors of Regions 2 & 4 to continue leading the organization forward in its mission, as the collective voice for the profession, to define and promote Cytotechnology.
Nominations are due Jan. 15, 2017.
Please send to:
ASCT, 1500 Sunday Drive, Suite 102
Raleigh, NC 27607
Phone: 800-948-3947 Email: info@asct.com
In addition to the Nomination Form, you must include a brief bio sketch and a current curriculum vitae including: Name of Nominee, Professional Certification, Education, and Professional Experience. Also email your headshot as a JPG attachment.
ASCT President-Elect form
REGIONAL DIRECTOR of ASCT for Regions 2 & 4
Medscape
From Oct. 12: Extending the screening interval for cervical cancer among women aged 40 years who test negative for human papillomavirus (HPV) is safe and does not increase the risk for either cancer or precancerous neoplasia, say Dutch researchers. On the basis of new data from the Netherlands, they suggest that the interval for cervical screening for such individuals (HPV-negative status and being older than 40 years) could be extended from 5 years to 10 years; all other women should continue to be screened every 5 years. The article was published online October 4 in the BMJ.
READ MORE
News-Medical
From Oct. 26: The American Society of Clinical Oncology (ASCO) issued a new global guideline on screening for cervical cancer, one of the leading causes of cancer related death among women worldwide. The guideline provides evidence-based recommendations for screening, follow-up of positive screening results, and treatment of women with cervical pre-cancers in countries worldwide.
READ MORE
| Date |
Event |
Location |
More information |
Jan. 18, 2017
2 p.m. EST
|
Simple & Potentially Life Saving, Exfoliative Anal Cytology |
Your PC |
 Charles D. Sturgis, MD
Associate Professor of Pathology
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland Clinic Staff Cytopathologist
R.J. Tomsich Pathology & Lab Medicine Institute
More info |
Register
|
February 15, 2017
2 p.m. EST
|
The Paris System of Reporting Urinary Cytology |
Your PC |
 Güliz A. Barkan, M.D., FIAC
Associate Professor of Pathology and Urology
Loyola University Healthcare System>
Maywood, Illinois
More info |
Register
|
March 15, 2017
2 p.m. EST
|
Evolution in Action: Cytotechnologists and USFNA |
Your PC |
 Adele O. Kraft, MD
Assistant Professor
Director, Cytopathology
Department of Pathology
 Mary Ellen Clark
Cytotechnologist
Virginia Commonwealth University Health System
Richmond, Virginia
More info |
Register
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
Cancer Network
From June 22: Testing for human papillomavirus infections in urine could be an extremely accurate way to exclude the possibility of such infections and screen for cervical cancer, according to a new study. The urinary testing includes HPV types not included in vaccines. High-risk HPV infections are the most important risk factor for developing cervical cancer as well as the cancer precursor lesions known as cervical intraepithelial neoplasias.
READ MORE
Medical Daily
From April 27: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. In 1983, scientists first published evidence showing HPV causes cervical cancer in women, and now it is also known to cause cancers of the anus, mouth/throat, and penis in men. Hoping to limit the spread of this noxious virus, American health authorities began recommending HPV vaccination in 2007 for all girls and women between the ages of 9 and 26, and in 2011 they extended this recommendation to boys and men between the ages of 11 and 21.
READ MORE
 |
|
The Cyto-Tek® 2500 offers excellent
preservation of cellular structure and consistently delivers a high rate of
cellular recovery. With its patented paced acceleration feature, the instrument
automatically increases and decreases the rotational velocity based on the selected
speed, which protects fragile cells and results in higher cellular yield.
|
|
Houston Chronicle
From March 23: A new study by researchers at Houston Methodist adds to a growing body of evidence that using both Pap smears and HPV tests will miss substantially fewer cervical cancers than either test alone. The use of Pap smears has dramatically reduced the incidence and the death rate from cervical cancer over the past 50 years. But the discovery that the human papillomavirus, or HPV, caused the vast majority of cervical cancer prompted the development of a direct test for the virus. In 2014, the Food and Drug Administration approved the virus test for cancer screening, prompting a debate over which test was better.
READ MORE
HealthDay News
From July 13: Cancers linked to the sexually transmitted human papillomavirus keep rising in the United States, even though most cases are preventable, health officials reported. Cervical cancer, and mouth and throat cancers in men, accounted for most of the nearly 39,000 HPV-associated cancers diagnosed annually from 2008 to 2012, according to the U.S. Centers for Disease Control and Prevention.
READ MORE
Healthline
From March 9: The majority of cervical cancer cases are caused by the human papillomavirus virus — or so we thought. Lately other links have been investigated and among them, rheumatoid arthritis. Now, RA has been shown to be associated with cervical cancer. And scientists are now faced with the question of what came first, the cancer or the RA? And did RA biologic treatment perhaps worsen or cause the cervical cancer? Researchers hope to uncover the answers to these questions as they strive to better understand the complex, puzzling link between autoimmune inflammatory conditions and various forms of cancer.
READ MORE
Forbes
From March 9: The human papillomavirus vaccine has slashed rates of the HPV strains covered by the vaccine by more than half in teens and by a third among women in their 20s, found a new study — and that's before the newest vaccine with greater coverage of HPV strains had even been introduced. HPV causes nearly all cervical cancers as well as a proportion of oral, vulvar, vaginal, penile and anal cancers.
READ MORE
Health Canal
From April 13: Researchers at the Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna General Hospital have developed a new treatment for the pre-stages of cervical cancer, caused by human papilloma virus (HPV) infection. The treatment involves using 85 percent trichloroacetic acid, an acid that is traditionally used for medical and cosmetic skin peeling. The scientists showed that complete remission was achieved in 82 percent of the patients after only one application. Moreover, the new treatment is very easy for experts to use and is very cost-effective.
READ MORE
ScienceDaily
From Aug. 24: A new study from the University of Illinois confirms a link between routine Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. However, most American health guidelines discourage women in that age range from receiving screenings unless they have pre-existing risk factors.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
